Capula Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$715K Sell
596
-2,903
-83% -$2.97M ﹤0.01% 328
2026
Q1
$3.22M Buy
3,499
+3,146
+891% +$3.19M 0.02% 176
2025
Q4
$379K Sell
353
-1,468
-81% -$1.4M ﹤0.01% 441
2025
Q3
$1.39M Buy
1,821
+1,334
+274% +$993K 0.01% 315
2025
Q2
$380K Sell
487
-386
-44% -$300K ﹤0.01% 263
2025
Q1
$721K Buy
873
+453
+108% +$377K ﹤0.01% 280
2024
Q4
$324K Sell
420
-88,164
-100% -$73M ﹤0.01% 222
2024
Q3
$78.5M Buy
88,584
+88,363
+39,983% +$79.4M 0.8% 12
2024
Q2
$200K Buy
+221
New +$177K ﹤0.01% 394
2023
Q4
– Sell
-620
Closed -$333K – 445
2023
Q3
$333K Buy
+620
New +$319K 0.01% 424
2023
Q2
– Sell
-19,806
Closed -$6.8M – 629
2023
Q1
$6.8M Sell
19,806
-6,688
-25% -$2.26M 0.08% 201
2022
Q4
$9.69M Buy
+26,494
New +$9.39M 0.13% 185
2022
Q3
– Sell
-11,509
Closed -$3.65M – 627
2022
Q2
$3.73M Buy
+11,509
New +$3.45M 0.06% 228
2021
Q4
– Sell
-8,439
Closed -$1.95M – 517
2021
Q3
$1.95M Buy
+8,439
New +$2.08M 0.02% 408
2021
Q1
– Sell
-1,776
Closed -$300K – 532
2020
Q4
$300K Buy
+1,776
New +$265K 0.01% 255
2020
Q2
– Sell
-14,024
Closed -$1.95M – 396
2020
Q1
$1.95M Buy
14,024
+12,824
+1,069% +$1.76M 0.07% 260
2019
Q4
$158K Buy
1,200
+300
+33% +$34.8K ﹤0.01% 347
2019
Q3
$101K Buy
+900
New +$100K ﹤0.01% 292

Other funds holding LLY

Capula Management's LLY Position: Q2 2026 in Review

Capula Management reduced its Eli Lilly (LLY) stake by 83% in Q2 2026, selling an estimated $2.97M and leaving 596 shares worth $715K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Capula Management first reported a position in LLY in Q3 2019 and has held it in 18 quarters since. The position peaked at $78.5M in Q3 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capula Management held 596 shares of Eli Lilly worth $715K as of Q2 2026.
  • Capula Management sold 2,903 Eli Lilly shares in Q2 2026, an estimated $2.97M.
  • Eli Lilly made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #328 holding.
  • Capula Management first reported a position in Eli Lilly in Q3 2019 and has held it in 18 quarters since.
  • Capula Management's Eli Lilly position peaked at $78.5M in Q3 2024.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.